These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 24375018)

  • 41. Human papillomavirus screening in north Indian women.
    Pandey S; Mishra M; Chandrawati
    Asian Pac J Cancer Prev; 2012; 13(6):2643-6. PubMed ID: 22938435
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence of human papillomavirus genotypes in women with normal and abnormal cervical cytology in Iran.
    Ghaffari SR; Sabokbar T; Mollahajian H; Dastan J; Ramezanzadeh F; Ensani F; Yarandi F; Mousavi-Jarrahi A; Mohagheghi MA; Moradi A
    Asian Pac J Cancer Prev; 2006; 7(4):529-32. PubMed ID: 17250423
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rationale and design of a multicenter prospective cohort study for the eVALuation and monitoring of HPV infections and relATEd cervical diseases in high-risk women (VALHIDATE study).
    Orlando G; Tanzi E; Chatenoud L; Gramegna M; Rizzardini G;
    BMC Cancer; 2012 May; 12():204. PubMed ID: 22646512
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of the clinical performance of carcinogenic HPV typing of the Linear Array and Papillocheck HPV-screening assay.
    Halfon P; Benmoura D; Khiri H; Penaranda G; Blanc B; Riggio D; Sandri MT
    J Clin Virol; 2010 Jan; 47(1):38-42. PubMed ID: 19939732
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Experience of Combined Liquid Based Cervical Cytology and High-Risk HPV mRNA for Cervical Cancer Screening in Thammasat University Hospital.
    Muangto T; Chanthasenanont A; Lertvutivivat S; Nanthakomon T; Pongrojpaw D; Bhamarapravatana K; Suwannarurk K
    Asian Pac J Cancer Prev; 2016; 17(9):4409-4413. PubMed ID: 27797253
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Human papillomavirus type-specific persistence and recurrence after treatment for cervical dysplasia.
    Söderlund-Strand A; Kjellberg L; Dillner J
    J Med Virol; 2014 Apr; 86(4):634-41. PubMed ID: 24123176
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Human papillomavirus infection in the female population of Antwerp, Belgium: prevalence in healthy women, women with premalignant lesions and cervical cancer.
    Baay MF; Tjalma WA; Weyler J; Goovaerts G; Buytaert P; Van Marck EA; Lardon F; Vermorken JB
    Eur J Gynaecol Oncol; 2001; 22(3):204-8. PubMed ID: 11501772
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Performance of HPV Genotyping Combined with p16/Ki-67 in Detection of Cervical Precancer and Cancer Among HPV-Positive Chinese Women.
    Jiang MY; Wu Z; Li T; Yu L; Zhang SK; Zhang X; Qu P; Sun P; Xi MR; Liu X; Liao G; Sun L; Zhang Y; Chen W; Qiao YL
    Cancer Prev Res (Phila); 2020 Feb; 13(2):163-172. PubMed ID: 31871224
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.
    Leinonen M; Nieminen P; Kotaniemi-Talonen L; Malila N; Tarkkanen J; Laurila P; Anttila A
    J Natl Cancer Inst; 2009 Dec; 101(23):1612-23. PubMed ID: 19903804
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence of type-specific HPV infection by age and grade of cervical cytology: data from the ARTISTIC trial.
    Sargent A; Bailey A; Almonte M; Turner A; Thomson C; Peto J; Desai M; Mather J; Moss S; Roberts C; Kitchener HC;
    Br J Cancer; 2008 May; 98(10):1704-9. PubMed ID: 18392052
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Detection and Genotyping of HPV DNA in a Group of Unvaccinated Young Women from Colombia: Baseline Measures Prior to Future Monitoring Program.
    Puerto D; Reyes V; Lozano C; Buitrago L; Garcia D; Murillo RH; Muñoz N; Hernandez GA; Sanchez L; Wiesner C; Combita AL
    Cancer Prev Res (Phila); 2018 Sep; 11(9):581-592. PubMed ID: 29991579
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Unexpected high prevalence of HPV 90 infection in an underserved population: is it really a low-risk genotype?
    Quiroga-Garza G; Zhou H; Mody DR; Schwartz MR; Ge Y
    Arch Pathol Lab Med; 2013 Nov; 137(11):1569-73. PubMed ID: 23425019
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence of high-risk human papillomavirus (HR-HPV) types 16 and 18 in healthy women with cytologically negative Pap smear.
    Arora R; Kumar A; Prusty BK; Kailash U; Batra S; Das BC
    Eur J Obstet Gynecol Reprod Biol; 2005 Jul; 121(1):104-9. PubMed ID: 15950365
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pre-vaccination epidemiology of human papillomavirus infections in Japanese women with abnormal cytology.
    Yamasaki K; Miura K; Shimada T; Ikemoto R; Miura S; Murakami M; Sameshima T; Fujishita A; Kotera K; Kinoshita A; Yoshiura K; Masuzaki H
    J Obstet Gynaecol Res; 2011 Nov; 37(11):1666-70. PubMed ID: 21793993
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevalence of human papillomavirus genotypes among women in Hunan province, China.
    Li H; Zhang J; Chen Z; Zhou B; Tan Y
    Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):202-5. PubMed ID: 23787251
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Large scale study of HPV genotypes in cervical cancer and different cytological cervical specimens in Thailand.
    Chansaenroj J; Junyangdikul P; Chinchai T; Swangvaree S; Karalak A; Gemma N; Poovorawan Y
    J Med Virol; 2014 Apr; 86(4):601-7. PubMed ID: 24127280
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High-risk HPV detection and associated cervical lesions in a population of French menopausal women.
    Tifaoui N; Maudelonde T; Combecal J; Vallo R; Doutre S; Didelot MN; Nagot N; Segondy M; Boulle N
    J Clin Virol; 2018 Nov; 108():12-18. PubMed ID: 30196012
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Population-based prevalence, type- and age-specific distribution of HPV in women before introduction of an HPV-vaccination program in Denmark.
    Kjaer SK; Breugelmans G; Munk C; Junge J; Watson M; Iftner T
    Int J Cancer; 2008 Oct; 123(8):1864-70. PubMed ID: 18661520
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Searching for an ideal cervical cancer screening model to reduce false-negative errors in a country with high prevalence of cervical cancer.
    Song T; Seong SJ; Lee SK; Kim BR; Ju W; Kim KH; Nam K; Sim JC; Kim TJ
    J Obstet Gynaecol; 2020 Feb; 40(2):240-246. PubMed ID: 31340702
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Prevalence of genotype-specific HPV infection among women in France: implications for screening and vaccination].
    Monsonego J; Zerat L; Syrjänen K; Zerat JC; Smith JS; Halfon P
    Gynecol Obstet Fertil; 2013 May; 41(5):305-13. PubMed ID: 23647817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.